A acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP of the European Pharmacopoeia monograph is often referred to as a acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium Certificate of Suitability (COS). The purpose of a acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium to their clients by showing that a acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP has been issued for it. The manufacturer submits a acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP holder for the record. Additionally, the data presented in the acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium DMF.
A acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of acetic acid; 2,3,4,5,6-pentahydroxyhexanal; sodium suppliers with CEP (COS) on PharmaCompass.